Update on Guidelines for the Management of Cancer‐Associated Thrombosis



lung dysplasia :: Article Creator

Vitamins & Supplements Center

Considering taking a vitamin or supplement to treat Bronchopulmonary+Dysplasia? Below is a list of common natural remedies used to treat or reduce the symptoms of Bronchopulmonary+Dysplasia. Follow the links to read common uses, side effects, dosage details and read user reviews for the drugs listed below.

13 results found for Bronchopulmonary+Dysplasia

Learn about User Reviews and read IMPORTANT information about user generated content

Conditions of Use and Important Information: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.

This copyrighted material is provided by Natural Medicines Comprehensive Database Consumer Version. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.© Therapeutic Research Faculty 2018.


Drugs For Treatment Of Bronchopulmonary Dysplasia Or Respiratory Insufficiency

'? Welcome to this page which serves as an archive for medications that are relevant to the

. The page includes both the generic and brand names and can serve as an invaluable resource for healthcare professionals and individuals who wish to get an insight on different medication options.

Click on a medication below to view details including brand names, prices, dosages, side effects, and administration guidelines.

A FAQ section has been added for each medication, addressing popular customer inquiries that provides a deeper insight into its use for

.

We recommend consulting your doctor to verify the information presented on this page or for any additional clarifications.


Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

Content

The role of infectious agents in cases of ARVD/C has been proposed due to the common finding of inflammatory infiltrates in the myocardium, suggesting that ARVD/C is a sequela of myocarditis (like dilated cardiomyopathy). A number of viruses have been identified in the hearts of patients with ARVD/C, myocarditis, or DCM. In 1986, a virus called Coxsackievirus B was identified in the hearts of patients with either myocarditis or DCM. Subsequently, it has been shown that another virus, called adenovirus, is also commonly a cause of these conditions.

It has been suggested that when the virus infects the heart, it causes the body to react against the virus, much as the body's own defense system (immune system) normally attacks a virus infection, and this causes inflammation in the heart (myocarditis). Usually the virus will be eliminated, however in some patients the immune system may not totally eliminate the virus, and in these patients, the heart muscle continues to be damaged, leading to DCM. In some people, the body's immune system attacks and damages the heart even though the virus has been eliminated: this is termed auto immune disease. It has been shown that in some patients with ARVD/C, adenovirus and Coxsackievirus may be disease-causing.

We have recently reported a study looking for evidence of virus infection of the heart in 12 patients with non-familial ARVD/C. Enteroviruses (the virus family which includes the Coxsackieviruses) were identified in seven patients and adenovirus type 5 in another two patients.

Investigations of the role of viruses in the development of ARVD/C are ongoing in the Phoebe Willingham Muzzy Pediatric Molecular Cardiology Laboratory, while viral diagnosis is provided by the John Welsh Cardiovascular Diagnostic Laboratory.






Comments

Popular posts from this blog

Epidemiology and prevention of venous thromboembolism